Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I. Sreevallika
P1.01-94 Phase I Trial to Establish Maximum Tolerated Dose Safety and Pharmacokinetic Profile of Oral Paclitaxel
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer
Clinical Cancer Research
Cancer Research
Oncology
Safety and Efficacy of the Maximum Tolerated Dose of Givinostat in Polycythemia Vera: A Two-Part Phase Ib/Ii Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
An Application of Reinforced Urn Processes to Determining Maximum Tolerated Dose
Statistics and Probability Letters
Uncertainty
Statistics
Probability
Correction: The Impact of Non-Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials
Clinical Cancer Research
Cancer Research
Oncology
Epacadostat Plus Pembrolizumab Is Well Tolerated in a Phase I Trial
Cancer Discovery
Oncology
The EZH2 Inhibitor Tazemetostat Is Well Tolerated in a Phase I Trial
Cancer Discovery
Oncology
Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
